Anxiolytic therapy and Weight decrease neonatal
Summary:
Weight decrease neonatal is found among people with Anxiolytic therapy, especially for people who are male, 60+ old.
The study analyzes which people have Weight decrease neonatal with Anxiolytic therapy. It is created by eHealthMe based on reports of 12 people who have Anxiolytic therapy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Anxiolytic therapy?
Anxiolytic therapy is found to be associated with 4,771 drugs and 5,656 conditions by eHealthMe. Check the latest studies of Anxiolytic therapy.
What is Weight decrease neonatal?
Weight decrease neonatal is found to be associated with 28 drugs and 114 conditions by eHealthMe. Check the latest studies of Weight decrease neonatal.
12 people who have Anxiolytic Therapy and Weight Decrease Neonatal are studied.

Gender of people who have Anxiolytic Therapy and experienced Weight Decrease Neonatal *:
- female: 41.67 %
- male: 58.33 %
Age of people who have Anxiolytic Therapy and experienced Weight Decrease Neonatal *:
- 0-1: 33.33 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 66.67 %
Common co-existing conditions for these people *:
- Depression: 6 people, 50.00%
- Drug Dependence: 5 people, 41.67%
- Rectal Cancer (cancer of rectum): 1 person, 8.33%
- Quit Smoking: 1 person, 8.33%
- Back Pain: 1 person, 8.33%
Common drugs taken by these people *:
- Zoloft: 6 people, 50.00%
- Subutex: 5 people, 41.67%
- Zantac: 5 people, 41.67%
- Macrobid: 5 people, 41.67%
- Suboxone: 4 people, 33.33%
- Sertraline Hydrochloride: 4 people, 33.33%
- Escitalopram: 3 people, 25.00%
- Fluorouracil: 1 person, 8.33%
- Ativan: 1 person, 8.33%
- Atropine: 1 person, 8.33%
Common symptoms for these people *:
- Jaundice Neonatal (yellowing of skin in neonate): 10 people, 83.33%
- Drug Withdrawal Syndrome Neonatal (prenatal nas is caused by discontinuation of drugs taken by the pregnant mother): 7 people, 58.33%
- Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 6 people, 50.00%
- Right Ventricular Hypertrophy (right ventricular enlargement): 5 people, 41.67%
- Right Atrial Dilatation (enlargement of the right atrium chamber of heart): 5 people, 41.67%
- Pulmonary Valve Disease: 5 people, 41.67%
- Cardiac Aneurysm (a condition that can occur after a myocardial infarction due to the inadequate resistance of the new scar tissue to the systolic pressure): 5 people, 41.67%
- Transposition Of The Great Vessels: 5 people, 41.67%
- Hypoglycaemia Neonatal (deficiency of glucose in the bloodstream in neonatal): 4 people, 33.33%
- Hyperbilirubinaemia Neonatal (excess of bilirubin in the blood in newborn): 4 people, 33.33%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Weight decrease neonatal?
- Check whether Weight decrease neonatal is associated with a drug or a condition (FREE)Related studies:
Treatments, associated drugs and conditions:
- Anxiolytic therapy (637,385 reports)
- Weight decrease neonatal (264 reports)
All the drugs that are associated with Weight decrease neonatal:
- Weight decrease neonatal (28 drugs)
All the conditions that are associated with Weight decrease neonatal:
- Weight decrease neonatal (114 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Weight decrease neonatal and Anxiolytic therapy, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Prochlorperazine and Nausea for Men aged 60+ - 2 seconds ago
- Drug interactions of Keppra and Lopurin - 10 seconds ago
- Acetaminophen and Deltasone drug interactions for men aged 40-49 - 18 seconds ago
- Drug interactions of Naloxone Hydrochloride and Dulcolax - 18 seconds ago
- Proair Hfa and Hot Flush for Women aged 40-49 - 21 seconds ago
- Proair Hfa and Menopause Hot Flashes for Women aged 40-49 - 22 seconds ago
- Proair Hfa and Hot Flash for Women aged 40-49 - 22 seconds ago
- Proair Hfa and Hot Flushes for Women aged 40-49 - 22 seconds ago
- Proair Hfa and Hot Flashes for Women aged 40-49 - 23 seconds ago
- Miralax and Double Vision for Men aged 50-59 - 27 seconds ago